IIM
MYGN icon

INTECH Investment Management’s Myriad Genetics MYGN Stock Holding History

INTECH Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Sell
23,833
-204,946
-90% -$1.07M ﹤0.01% 1880
2025
Q4 		$1.41M Buy
228,779
+193,215
+543% +$1.4M 0.01% 937
2025
Q3 		$257K Sell
35,564
-19,537
-35% -$116K ﹤0.01% 1914
2025
Q2 		$293K Sell
55,101
-36,837
-40% -$218K ﹤0.01% 1876
2025
Q1 		$815K Buy
91,938
+5,760
+7% +$69.2K 0.01% 1324
2024
Q4 		$1.18M Buy
86,178
+57,123
+197% +$1.05M 0.01% 1024
2024
Q3 		$796K Buy
29,055
+7,043
+32% +$191K 0.01% 947
2024
Q2 		$538K Buy
+22,012
New +$483K 0.01% 786

Other funds holding MYGN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return